ATEC
Alphatec Holdings, Inc.NASDAQHealthcare$10.83-3.82%ClosedMarket Cap: $1.64B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
45.69
P/S
2.17
EV/EBITDA
-48.21
DCF Value
$11.19
FCF Yield
0.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.1%
Operating Margin
-10.3%
Net Margin
-18.8%
ROE
-1760.5%
ROA
-18.1%
ROIC
-12.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $212.9M | 61.2% | $-5.4M | $-21.7M | $-0.15 | — |
| FY 2025 | $764.2M | 69.6% | $-82.1M | $-143.4M | $-0.96 | — |
| Q3 2025 | $196.5M | 69.9% | $-15.9M | $-28.6M | $-0.19 | — |
| Q2 2025 | $185.5M | 69.6% | $-13.1M | $-41.1M | $-0.27 | — |
| Q1 2025 | $169.2M | 68.6% | $-44.3M | $-51.9M | $-0.35 | — |
| Q4 2024 | $176.8M | 68.8% | $-23.8M | $-33.3M | $-0.23 | — |
| FY 2024 | $611.6M | 69.4% | $-136.2M | $-162.1M | $-1.13 | — |
| Q3 2024 | $150.7M | 68.2% | $-33.7M | $-39.6M | $-0.28 | — |
| Q2 2024 | $145.6M | 70.5% | $-35.3M | $-40.7M | $-0.29 | — |
| Q1 2024 | $138.5M | 70.3% | $-43.3M | $-48.5M | $-0.34 | — |
| Q4 2023 | $138.0M | 69.0% | $-44.8M | $-49.1M | $-0.37 | — |
| FY 2023 | $482.3M | 64.3% | $-173.4M | $-186.6M | $-1.54 | — |